Financial Barriers In Clinical Trials: What Patient Data Tells Us

By Heather Horville, Solutions Consultant at Suvoda

While eligibility criteria and geographic access frequently dominate discussions surrounding trial accessibility, hidden economic strains quietly undermine enrollment and retention. Global data reveals that financial transparency is a primary decider for prospective participants—ranking directly behind study safety and clinic location. Yet, one in three clinical trial volunteers receives no compensation or reimbursement, leaving many to shoulder out-of-pocket costs for travel, lodging, and childcare while managing demanding health conditions.

When participants endure cumbersome payment processes or unexpected personal expenditures, participation becomes an unsustainable financial trade-off.  To honor patient altruism and build equitable studies, trial designs must treat financial support as a core pillar of the patient experience. Offering flexible payment choices, upfront travel coverage, and transparent tracking removes artificial barriers to care. Streamlining these workflows protects participants from bearing the financial cost of medical progress, ultimately yielding stronger retention, richer trial diversity, and more resilient clinical outcomes.